Header Logo

Connection

SYED ZAID to Risk Factors

Back to Details
This is a "connection" page, showing publications SYED ZAID has written about Risk Factors.
SYED ZAID
Connection Strength
0.853
Risk Factors
  1. Challenges and Future Directions in Redo Aortic Valve Reintervention After Transcatheter Aortic Valve Replacement Failure. Circ Cardiovasc Interv. 2023 11; 16(11):e012966.
    View in: PubMed
    Score: 0.082
  2. What's New with TAVR? An Update on Device Technology. Methodist Debakey Cardiovasc J. 2023; 19(3):4-14.
    View in: PubMed
    Score: 0.079
  3. Impact of Functional Status on TAVI Outcomes. Cardiovasc Revasc Med. 2022 05; 38:27-28.
    View in: PubMed
    Score: 0.073
  4. Novel Predictors of New Persistent Left Bundle Branch Block After SAPIEN 3 Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2020 05 11; 13(9):1141-1143.
    View in: PubMed
    Score: 0.063
  5. Novel Anatomic Predictors of New Persistent Left Bundle Branch Block After Evolut Transcatheter Aortic Valve Implantation. Am J Cardiol. 2020 04 15; 125(8):1222-1229.
    View in: PubMed
    Score: 0.063
  6. Meta-Analysis of Dedicated vs Off-Label Transcatheter Devices for Native Aortic Regurgitation. JACC Cardiovasc Interv. 2025 Jan 13; 18(1):44-57.
    View in: PubMed
    Score: 0.022
  7. Impact of systolic dominant pulmonary venous flow morphology on outcomes after mitral transcatheter edge-to-edge repair. Catheter Cardiovasc Interv. 2024 Nov; 104(5):1027-1036.
    View in: PubMed
    Score: 0.022
  8. A Guide to Transcatheter Aortic Valve Design and Systematic Planning for a Redo-TAV (TAV-in-TAV) Procedure. JACC Cardiovasc Interv. 2024 Jul 22; 17(14):1631-1651.
    View in: PubMed
    Score: 0.021
  9. In Vivo Computed Tomography Sizing for Redo-Transcatheter Aortic Valve Replacement in Evolut Valves: Impact on Sizing, Feasibility, and Prosthesis-Patient Mismatch. Circ Cardiovasc Interv. 2024 Aug; 17(8):e013903.
    View in: PubMed
    Score: 0.021
  10. Impact of Left Atrial Pressure on Outcomes After Mitral Transcatheter Edge-to-Edge Repair. Circ Cardiovasc Interv. 2024 Sep; 17(9):e014055.
    View in: PubMed
    Score: 0.021
  11. Infection of Transcatheter Valvular Devices. Curr Cardiol Rep. 2024 Jul; 26(7):767-775.
    View in: PubMed
    Score: 0.021
  12. Percutaneous coronary intervention before transcatheter aortic valve implantation: A propensity score matched analysis. Cardiovasc Revasc Med. 2024 Aug; 65:10-15.
    View in: PubMed
    Score: 0.021
  13. Ventricular arrhythmias prior to continuous flow left ventricular assist device implantation were not associated with reduced 1-year mortality: a single-center experience. J Interv Card Electrophysiol. 2024 Jun; 67(4):705-707.
    View in: PubMed
    Score: 0.021
  14. Explant vs Redo-TAVR After Transcatheter Valve Failure: Mid-Term Outcomes From the EXPLANTORREDO-TAVR International Registry. JACC Cardiovasc Interv. 2023 04 24; 16(8):927-941.
    View in: PubMed
    Score: 0.020
  15. Effect of BMI on patients undergoing transcatheter aortic valve implantation: A systematic review and meta-analysis. Prog Cardiovasc Dis. 2023 May-Jun; 78:58-66.
    View in: PubMed
    Score: 0.019
  16. MitraClip for Severe Mitral Regurgitation from Chordal Rupture during Balloon Aortic Valvuloplasty. Methodist Debakey Cardiovasc J. 2022; 18(1):73-77.
    View in: PubMed
    Score: 0.019
  17. Rationale, Definitions, Techniques, and?Outcomes of Commissural Alignment?in TAVR: From the ALIGN-TAVR Consortium. JACC Cardiovasc Interv. 2022 08 08; 15(15):1497-1518.
    View in: PubMed
    Score: 0.019
  18. Outcomes and feasibility of redo-TAVR after Sapien 3 Ultra TAVR in extremely-undersized?versus nominally-sized annuli. Catheter Cardiovasc Interv. 2022 05; 99(6):1935-1944.
    View in: PubMed
    Score: 0.018
  19. Outcomes of SAPIEN 3 Ultra TAVR in Extremely Undersized Versus Equivalent Nominally Sized Anatomies. JACC Cardiovasc Interv. 2022 02 28; 15(4):463-466.
    View in: PubMed
    Score: 0.018
  20. Trends and Outcomes of Transcatheter Versus Surgical Aortic Valve Implantation in Patients on Chronic Steroids. Am J Cardiol. 2022 03 15; 167:157-159.
    View in: PubMed
    Score: 0.018
  21. Surgical Explantation After TAVR Failure: Mid-Term Outcomes From the EXPLANT-TAVR International?Registry. JACC Cardiovasc Interv. 2021 09 27; 14(18):1978-1991.
    View in: PubMed
    Score: 0.018
  22. Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement. Cardiovasc Revasc Med. 2022 03; 36:9-13.
    View in: PubMed
    Score: 0.017
  23. Readmission following urgent transcatheter aortic valve implantation versus urgent balloon aortic valvuloplasty in patients with decompensated heart failure or cardiogenic shock. Catheter Cardiovasc Interv. 2021 09; 98(3):607-612.
    View in: PubMed
    Score: 0.017
  24. Temporal Trends and Outcomes of Transcatheter Versus Surgical?Aortic Valve Replacement in?Patients With?Renal?Transplants. JACC Cardiovasc Interv. 2020 09 28; 13(18):2188-2190.
    View in: PubMed
    Score: 0.016
  25. Third-Generation Balloon and Self-Expandable Valves for Aortic Stenosis in Large and Extra-Large Aortic Annuli From the TAVR-LARGE Registry. Circ Cardiovasc Interv. 2020 08; 13(8):e009047.
    View in: PubMed
    Score: 0.016
  26. Radial vs. Femoral Access for Percutaneous Coronary Artery Intervention in Patients With ST-Elevation Myocardial Infarction. Cardiovasc Revasc Med. 2021 07; 28:57-64.
    View in: PubMed
    Score: 0.016
  27. Prosthesis-Patient Mismatch Between Transcatheter Heart Valves in?TAVR Using a Computed Tomography-Derived Comparative Model. JACC Cardiovasc Interv. 2020 03 23; 13(6):790-792.
    View in: PubMed
    Score: 0.016
  28. Trends and Outcomes With Transcatheter Versus Surgical Mitral Valve Repair in Patients =80 Years of Age. Am J Cardiol. 2020 04 01; 125(7):1083-1087.
    View in: PubMed
    Score: 0.016
  29. Mid-Term Outcomes of Transcatheter Aortic Valve Replacement in Extremely Large?Annuli With Edwards SAPIEN 3 Valve. JACC Cardiovasc Interv. 2020 01 27; 13(2):210-216.
    View in: PubMed
    Score: 0.016
  30. Feasibility of Repeat TAVR?After SAPIEN 3 TAVR: A Novel Classification Scheme and Pilot?Angiographic Study. JACC Cardiovasc Interv. 2019 07 08; 12(13):1290-1292.
    View in: PubMed
    Score: 0.015
  31. Transcatheter Valve Neo-Commissural Overlap With Coronary Orifices After Transcatheter Aortic Valve Replacement. Circ Cardiovasc Interv. 2018 10; 11(10):e007263.
    View in: PubMed
    Score: 0.014
  32. Impact of Aortic Root Anatomy and Geometry on Paravalvular Leak in Transcatheter Aortic Valve Replacement With Extremely Large Annuli Using the Edwards SAPIEN 3 Valve. JACC Cardiovasc Interv. 2018 07 23; 11(14):1377-1387.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.